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Summary
Human transferrin receptor 1 (TfR) binds iron-loaded
transferrin (Fe-Tf) and transports it to acidic endo-
somes where iron is released in a TfR-facilitated pro-
cess. Consistent with our hypothesis that TfR binding
stimulates iron release from Fe-Tf at acidic pH by stabi-
lizing the apo-Tf conformation, a TfR mutant (W641A/
F760A-TfR) that binds Fe-Tf, but not apo-Tf, cannot
stimulate iron release from Fe-Tf, and less iron is re-
leased from Fe-Tf inside cells expressing W641A/
F760A-TfR than cells expressing wild-type TfR (wtTfR).
Electron paramagnetic resonance spectroscopy shows
that binding at acidic pH to wtTfR, but not W641A/
F760A-TfR, changes the Tf iron binding site R30 A˚
from the TfR W641/F760 patch. Mutation of Tf histidine
residues predicted to interact with the W641/F760
patch eliminates TfR-dependent acceleration of iron
release. Identification of TfR and Tf residues critical for
TfR-facilitated iron release, yet distant from a Tf iron
binding site, demonstrates that TfR transmits long-
range conformational changes and stabilizes the con-
formation of apo-Tf to accelerate iron release from
Fe-Tf.
Introduction
Iron is a fundamental nutrient required by all cell types
for sustaining numerous cellular processes. The primary
pathway for iron uptake by most mammalian cells in-
volves the human transferrin receptor 1 (TfR), a dimeric
transmembrane glycoprotein that traffics between the
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Massachusetts 02140.cell surface and acidic intracellular compartments (Enns,
2002). At the slightly basic pH of the cell surface (pH 7.4),
TfR binds iron-loaded transferrin (Fe-Tf) (Leibman and
Aisen, 1977), an iron transport protein present in blood.
Fe-Tf binds to the TfR at pH 7.4 with an equilibrium dis-
sociation constant (KD) ofw1 nM (Giannetti et al., 2003).
Fe-Tf/TfR complexes are transported to acidic endo-
somes where iron is released from Fe-Tf in a TfR-
assisted process (Bali et al., 1991; Sipe and Murphy,
1991; Zak and Aisen, 2003). The resulting iron-free trans-
ferrin (apo-Tf) remains bound to TfR at acidic pH (KDw5
nM) (Giannetti et al., 2003) during recycling of apo-Tf/TfR
complexes back to the cell surface, but dissociates from
TfR upon exposure to the slightly basic pH of blood
(Dautry-Varsat et al., 1983).
Crystallographic studies have revealed the structures
of TfR and of several Tf family members (Lindley, 2001).
The crystal structure of the soluble ectodomain of TfR
has been reported alone (Lawrence et al., 1999) and in
complex with HFE (Bennett et al., 2000), the protein mu-
tated in patients with the iron overload disorder heredi-
tary hemochromatosis (Feder et al., 1996). Each chain
of the dimeric TfR ectodomain is composed of three
structural domains: a protease-like domain resembling
amino- and carboxypeptidases (residues 121–188 and
384–606), an apical domain (residues 189–383), and a he-
lical domain involved in homodimerization (residues
607–760) (Figure 1A). Membrane-bound TfR also in-
cludes a glycosylated stalk region, a transmembrane re-
gion, and an N-terminal cytoplasmic domain. Transferrin
contains two w40 kDa lobes (the N- and C-lobes) that
are related by sequence and structural homology (Fig-
ure 1B). Each lobe consists of two domains (N-I and
N-II in the N-lobe; C-I and C-II in the C-lobe). A single
Fe3+ ion binds deep within a cleft formed at the interface
between the two domains of each lobe. Each iron ion is
coordinated by six groups: four side chains from Tf (two
tyrosine residues, one histidine, and one aspartate) and
two oxygen atoms from the synergistic anion bicarbon-
ate (MacGillivray et al., 1998). Physiologically, iron-
loaded Tf exists as a mixture of monoferric and diferric
species. Here we refer to the mixture as Fe-Tf and spe-
cifically to diferric Tf as Fe2-Tf.
Iron release from Fe2-Tf results in large conforma-
tional changes in each lobe and in the interface between
lobes (MacGillivray et al., 1998). The conformational
changes include a 54º–63º rotation between the do-
mains comprising each lobe and a repacking of the in-
terface between each lobe, burying previously exposed
residues and exposing previously buried residues (Ger-
stein et al., 1993) (Figure 1B). It is presumed that the con-
formational changes resulting from iron loss occur while
Tf is bound to TfR in acidic vesicles, as the two proteins
remain complexed throughout endocytosis and recy-
cling (Dautry-Varsat et al., 1983). Iron release studies
show that iron dissociates slowly from Tf at pH 7.4 in
the absence of a chelator (half-life > days) (Aisen and
Leibman, 1968). The rate is accelerated at the acidic
pH of endosomes (half-life > 3 hr at pH 5.5) (reviewed
in He and Mason, 2002), but is still slow compared
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1614Figure 1. Structures of TfR, Fe2-Tf/TfR, Fe2-Tf, and apo-Tf
(A) Structure of the TfR homodimer alone (Lawrence et al., 1999) (left) and bound to Fe2-Tf (Cheng et al., 2004) (right). One of the TfR chains is
brown and the other is color coded to differentiate the three domains. The positions of residues contributing significantly to Fe2-Tf binding (Gian-
netti et al., 2003) are highlighted in yellow and the side chains of residues specific for binding apo-Tf (W641 and F760) are highlighted in green.
(B) Ribbon diagrams of diferric ovotransferrin (Kurokawa et al., 1995) and apo-ovotransferrin (Kurokawa et al., 1999) to represent the structures of
human Fe2-Tf and apo-Tf. Side chains of residues coordinating the iron ions (red spheres) in the diferric structure are shown as sticks and colored
by atom type.with the rate observed for transfer of iron from Tf/TfR
complexes to the cytoplasm (2–3 min) (Aisen and Leib-
man, 1973). The ability of TfR to accelerate the release
of iron from Tf at acidic pH compared to the iron release
rate for free Tf (Bali et al., 1991; Zak and Aisen, 2003),
combined with the actions of anions and chelators, sug-
gests that iron can be released inside acidic endosomes
during a single round of endocytosis and recycling.
However, the mechanism by which TfR facilitates iron
release from Tf is not known.
Understanding the mechanism of TfR-facilitated iron
release from Tf requires structural information about
how TfR binds to both Fe-Tf and apo-Tf. Competition
(Lebro´n et al., 1999), mutagenesis (Giannetti et al.,
2003), and time-resolved X-ray footprinting (Liu et al.,
2003) studies have mapped the binding site on TfR for
Tf, revealing that the Tf C-lobe binds to the central por-
tion of the TfR helical domain and the Tf N-lobe contacts
the bottom of the TfR protease-like domain. Consistent
with the mutagenesis and mapping results, aw7.5 A˚ res-
olution structure of an Fe2-Tf/TfR complex derived by
cryo-electron microscopy shows the Tf C-lobe contact-
ing the TfR helical domain and the Tf N-lobe making con-
tacts with the TfR protease-like domain (Cheng et al.,
2004). Apo-Tf is believed to bind to TfR in a similar man-
ner, based on the observation that most substitutions
that strongly reduce Fe2-Tf binding to TfR at basic pH ex-
hibit a similar reduction of apo-Tf binding at pH 6.3 (Gian-netti et al., 2003). However, at least some differences in
the specific contacts of apo-Tf versus Fe2-Tf to TfR are
suggested by two substitutions in TfR (W641A and
F760A) (Figure 1A), which reduce binding to apo-Tf with-
out significantly affecting binding to Fe2-Tf (Giannetti
et al., 2003). From these results, we suggested that spe-
cific pH-dependent contacts between Tf and the W641/
F760 region of TfR stabilize an open conformation of
the Tf C-lobe, thereby allowing protons and chelators
to more easily access the Fe3+ binding site and acceler-
ate iron release from TfR-bound Tf (Giannetti et al., 2003).
To further evaluate the involvement of the apo-Tf-
specific region of TfR in affecting iron release from Tf,
we produced a double mutant form of soluble TfR
(W641A/F760A-TfR) and mutant Tf molecules and stud-
ied their properties using a combination of biochemical
and biophysical assays. The TfR mutant binds Fe2-Tf at
basic pH with wild-type affinity, but shows a greatly re-
duced affinity for binding apo-Tf at acidic pH. Compari-
son of iron release rates at acidic pH from Tf bound to
wild-type TfR (wtTfR) versus W641A/F760A-TfR shows
that the mutant TfR does not accelerate iron release
from Tf, and less iron is released from Fe2-Tf taken up
by cells expressing W641A/F760A-TfR as compared to
wtTfR. Electron paramagnetic resonance (EPR) spectra
show that binding to wtTfR at acidic pH alters the en-
vironment of the iron ion in the Tf C-lobe, whereas bind-
ing to W641A/F760A-TfR does not, suggesting that
Mechanism of TfR-Stimulated Iron Release from Tf
1615Figure 2. SPR Analysis of Fe2-Tf and apo-Tf
Binding to wtTfR and W641A/F760A-TfR at
pH 7.4 and pH 6.3
Experimentally observed responses are
shown as black lines with the best fit binding
curves (red lines) derived from a bivalent li-
gand model (Giannetti and Bjorkman, 2004;
Giannetti et al., 2003) superimposed. Resid-
uals between fits and data are shown below
each panel. The highest concentrations in
the injection series for each sensorgram are
73 nM for the experiments involving Fe2-Tf
and 625 nM and 10 mM for the experiments in-
volving apo-Tf binding to wtTfR and W641A/
F760A-TfR, respectively. Subsequent injec-
tions are related by 3-fold (Fe-Tf) and 2-fold
dilutions (apo-Tf). Sensorgrams for the other
binding reactions summarized in Table 1 are
shown in Figure S1.interaction with TfR residues W641 and F760 confers
a structural change in the Tf C-lobe. Substitution of
two Tf histidines (H349 and H350) predicted to be near
TfR residues W641 and F760 in the TfR/Fe2-Tf complex
(Cheng et al., 2004) reduces the ability of TfR to facilitate
iron release from the Tf C-lobe, suggesting that these
histidines are part of the trigger for iron release. The re-
sults are interpreted using available structural informa-
tion to facilitate an understanding of how TfR binding ac-
celerates iron release from Tf.
Results
Production and Tf Binding Properties of Wild-Type
and Mutant TfRs
Two amino acid substitutions previously identified to
lower the binding affinity of TfR for apo-Tf at pH 6.3
but not Fe2-Tf at pH 7.4, W641A (w56-fold reduction)
and F760A (w16-fold reduction) (Giannetti et al., 2003),
were combined to produce soluble W641A/F760A-TfR.
To evaluate the binding characteristics of W641A/
F760A-TfR compared to wtTfR, we derived equilibrium
dissociation constants (KDs) for binding to Fe2-Tf at pH
7.4 and to apo-Tf at acidic pH using a surface plasmon
resonance (SPR) binding assay (Giannetti et al., 2003).
W641A/F760A-TfR exhibits the expected properties,
binding to Fe2-Tf at pH 7.4 with no reduction in affinity
compared to wtTfR, and affinity reductions between
400- and >1000-fold for binding to apo-Tf at pH 6.3
and 5.6 (Figure 2; see Figure S1 in the Supplemental
Data available with this article online; Table 1). By con-
trast to the reduced affinity exhibited by W641A/
F760A-TfR for apo-Tf at acidic pH, it retains near wild-
type affinity for binding to Fe2-Tf at acidic pH (Table 1;
Figure S1). Measurements of Fe2-Tf binding to TfR at
acidic pH are possible because iron is not released on
the timescale of the binding experiment in the absence
of a chelator (P.J.H. and A.B.M., unpublished results).
Comparison of TfR-Facilitated Iron Release from Tf
Bound to wtTfR versus W641A/F760A-TfR
We next sought to determine the effects of a reduced
binding affinity at acidic pH for apo-Tf, but not Fe2-Tf,on the ability of W641A/F760A-TfR to facilitate iron re-
lease from Tf. Iron release kinetics from Fe2-Tf are com-
plicated by different release rates from the N- and C-
lobes (Bali and Harris, 1989) and by the influence of the
iron status of the N-lobe on the release rate from the C-
lobe (Zak and Aisen, 2003). Because only the C-lobe of
Tf makes significant interactions with the TfR helical do-
main (Cheng et al., 2004; Giannetti et al., 2003; Liu et al.,
2003), which contains the hydrophobic patch formed by
W641 and F760, we conducted iron release assays using
a mutant form of Tf that binds iron in the C- but not N-
lobe, referred to here as FeC-Tf, and in other studies as
N-His-Y95F/Y188F hTf-NG (Mason et al., 2004).
Iron release rates were measured using a spectrofluo-
rometric assay, which monitors iron release by an in-
crease in fluorescence (Zak and Aisen, 2003), for FeC-
Tf alone and for FeC-Tf bound to wtTfR or to W641A/
F760A-TfR. Comparison of iron release rates at pH 5.6
from FeC-Tf alone and FeC-Tf bound to wtTfR shows
that TfR binding increases the rate byw100-fold (Figure
3; Table 1). By contrast, binding of W641A/F760A-TfR
does not increase the iron release rate. Instead, the
rate is decreased by a factor of two compared with the
rate for free FeC-Tf and is thus 200-fold slower than
the rate for FeC-Tf bound to wtTfR (Figure 3; Table 1);
that is, binding to W641A/F760A-TfR retards, rather
than accelerates, iron release from FeC-Tf.
Comparison of Iron Release from Fe2-Tf in Cells
Expressing wtTfR and Mutant TfR
To determine the effect of the W641A and F760A substi-
tutions in TfR on the amount of iron released intracellu-
larly from Fe2-Tf added exogenously to cells, we utilized
Chinese hamster ovary cell lines that either express
no endogenous TfR (TRVb cells), express human TfR
(TRVb-1 cells; referred to here as TRVb-wtTfR) (McGraw
et al., 1987), or express W641A/F760A-TfR (TRVb-
W641A/F760A-TfR). The TfR construct used to create
the TRVb-W641A/F760A-TfR cell line does not contain
iron-responsive elements (Rouault and Klausner, 1997),
and thus the levels of W641A/F760A-TfR expressed are
not controlled by iron. The three cell lines were incubated
at 4ºC with radio-iodinated Fe2-Tf (
125I-Fe2-Tf) to
Structure
1616Table 1. Affinities of Wild-Type and Mutant TfR and Fe-Tf Molecules and Iron Release Rates
Affinities of Wild-Type and Mutant TfR for Fe2-Tf and apo-Tf and Effects on Iron Release from Fec-Tf
wtTfR
KD1, KD2 (nM)
W641A/F760A-TfR
KD1, KD2 (nM)
apo +Fe apo +Fe
pH 7.4 1.4, 9.6 3.3, 45
[KD(mut)/KD(wt)] [2.4, 4.7]
pH 6.3 7.8, 67 4.5, 49 3100, 35000 5.6, 57
[KD(mut)/KD(wt)] [400, 520] [1.2, 1.2]
pH 5.6 1.5, 1.8 9.8, 220 a 29, 380
[KD(mut)/KD(wt)] [>1000] [3.0, 1.7]
Iron Release Rate:
Kobs (s
21 3 103)
Fec-Tf alone 2.6 6 0.2 2.6 6 0.2
Fec-Tf + TfR 270 6 46 1.3 6 0.03
[Rate enhancement
due to TfR]
[104] [0.5]
Affinities of Fec-Tf and Fec-Tf Mutants for wtTfR and Iron Release Rates
Fec-Tf
KD or
KD1, KD2
(nM)
H349A-Fec-Tf
KD or
KD1, KD2
(nM)
H349K-Fec-Tf
KD or
KD1, KD2
(nM)
H350A-Fec-Tf
KD or
KD1, KD2
(nM)
H350D-Fec-Tf
KD or
KD1, KD2
(nM)
H349K/H350A-
Fec-Tf
KD or
KD1, KD2 (nM)
pH 7.4 (iron-loaded) 58 58 79 71 b 120
[KD(mut)/KD(wt)] [1.0] [1.4] [1.2] [2.1]
pH 6.3 (apo) 3.1, 47 240, 510 66, 100 8.1, 55 4.9, 50 110, 490
[KD(mut)/KD(wt)] [77, 11] [21, 2.1] [2.6, 1.2] [1.6, 1.1] [36, 10]
pH 5.6 (apo) 0.42, 3.6 9.3, 12 2.6, 16 0.94, 5.5 0.30, 0.81 2.8, 55
[KD(mut)/KD(wt)] [22, 3.3] [6.2, 4.4] [2.2, 1.5] [0.71, 0.23] [6.7, 15]
Iron release rate:
Kobs (s
21 3 103)
Fec-Tf alone 2.6 6 0.2 3.6 6 0.2 6.4 6 1.3 3.8 6 0.2 4.3 6 0.6 5.5 6 1.1
Fec-Tf + TfR 270 6 46 5.1 6 0.2 7.1 6 0.4 98 6 1.7 104 6 7.8 5.7 6 0.3
[Rate enhancement
due to TfR]
[104] [1.4] [1.1] [26] [24] [1.0]
The KDs for binding of wild-type and mutant Tfs to wtTfR and W641A/F760A-TfR were derived from fits to sensorgrams as shown in Figure 2.
Numbers in brackets below the KD1 and KD2 values are the ratio of the KD of the mutant to the relevant wild-type protein control. KDs are reported
as the average derived from injections over two adjacent flow cells on the same biosensor chip. KD values generally agreed to within 4%. Iron
release rates are presented for wild-type and mutant FeC-Tf molecules alone and bound to wild-type and mutant TfRs. Numbers in brackets
below the iron release rates are the ratio of the iron release rate of the TfR-bound Tf to the release rate of the Tf alone.
a Binding was too weak to derive an accurate affinity.
b Unable to derive an accurate affinity using a 1:1 binding model.evaluate binding of Tf to cell surface TfR, and at 37ºC
with either 125I-Fe2-Tf to determine the amount of inter-
nalized Tf protein in endosomes, or with 55Fe-labeled
Fe2-Tf (
55Fe2-Tf) to determine the amount of iron re-
leased from internalized Tf into the cytosol. The ratios
of these numbers were used to determine the iron re-
lease efficiency (see Experimental Procedures).
Figure 4 shows one of three independent binding
and internalization experiments. Measurements of the
amounts of 125I-Fe2-Tf bound to the TRVb-wtTfR and
TRVb-W641A/F760A-TfR cell lines at 4ºC demonstrated
that the TRVb-W641A/F760A-TfR cells expressed
higher levels of cell surface TfR than the TRVb-wtTfR
cells (Figure 4, left), thus the TRVb-W641A/F760A-TfR
cells internalize more 125I-Fe2-Tf (Figure 4, middle). De-
spite taking up more Fe2-Tf, measurements of internally
released 55Fe show that the TRVb-W641A/F760A-TfRcells acquire less iron from Tf than the TRVb-wtTfR cells
(Figure 4, right), demonstrating that iron is released from
Tf less efficiently in cells expressing W641A/F760A-TfR
than in cells expressing wtTfR. From three independent
binding and uptake experiments, we calculate that the
amount of iron released from Fe2-Tf is reduced by
33% 6 20% in the TRVb-W641A/F760A-TfR cells as
compared with the wtTfR-expressing cells.
TfR W641 and F760 Affect the Tf C-Lobe Ferric Iron
Binding Site
Having identified TfR residues that are critical for TfR-
facilitated iron release from Tf, we next monitored the
iron ion in the Tf C-lobe by EPR spectroscopy to assess
potential changes induced by binding wild-type versus
mutant TfR. The EPR spectrum of FeC-Tf alone at pH
7.4 shows hyperfine splitting at g0 = 4.3 that results in
Mechanism of TfR-Stimulated Iron Release from TfFigure 3. Kinetics of Iron Release from FeC-Tf—a Mutant Form of Tf that Binds Iron in the C-Lobe, but Not the N-Lobe—Alone and in Complex
with TfR Proteins at pH 5.6
Release was monitored as a change in relative fluorescence intensity versus time. Loss of iron results in an increase in fluorescence signal that
was fit to a first-order rate equation to derive the rate constants shown in Table 1. The FeC-Tf/wtTfR complex (inset) rapidly achieved complete
release.three peaks characteristic of Fe-Tf (Figure 5) (Chasteen,
1983). To collect spectra at acidic pH, we developed
a rapid acidification and freezing procedure that mini-
mizes spontaneous iron release and protein precipita-
tion (Experimental Procedures). The features of the
EPR spectra obtained at pH 5.6 and pH 7.4 are indistin-
guishable (Figure 5), even though acidic pH accelerates
the rate of iron release from Tf and its conformational dy-
namics (He and Mason, 2002; Navati et al., 2003). Thus,
low pH alone does not disturb the iron binding site within
the limits of EPR detection. TfR binding at pH 7.4 has no
effect on the EPR spectrum of Tf, as shown by previous
studies involving iron-loaded Tf C-lobe (Zak and Aisen,
2003). At pH 5.6, however, TfR binding changes the
EPR spectrum of FeC-Tf such that the high field peak
is reduced in intensity (Figure 5). A qualitatively similar
spectrum was reported for a Tf N-lobe mutant (D63S)
in which one iron-coordinating residue was substituted.
The EPR spectrum of the N-lobe mutant was shown to
represent a mixture of states (Grady et al., 1995), which
may also be the case for the EPR spectrum of FeC-Tf
bound to TfR at pH 5.6.
By contrast to the changes in the EPR spectrum re-
sulting from binding to wtTfR at acidic pH, binding to
W641A/F760A-TfR at pH 5.6 does not affect the EPR
spectrum of FeC-Tf (Figure 5). Therefore, TfR-induced
perturbations to the iron binding site of the Tf C-lobe re-
quire the presence of TfR residues W641 and F760. The
iron ion being monitored by EPR is predicted to be about
30 A˚ away from the W641/F760 patch on TfR that is crit-
ical for TfR-mediated facilitation of iron release (mea-
sured using Protein Data Bank code 1SUV; Cheng
et al., 2004), thus the W641A/F760-specific changes
are transmitted over a long distance.Tf Histidines Receive a Signal from TfR to Induce
Iron Release
Given that W641 and F760 are integral to apo-Tf binding
and TfR’s activity in stimulating iron release, we hypoth-
esized that residues on Tf interact with the W641/F760
region of TfR to receive a signal from TfR that stimulates
iron release. Inspection of the 7.5 A˚ resolution electron
microscopy (EM) structure of the Tf/TfR complex (Cheng
et al., 2004) shows that the Tf residues predicted to be
closest to the W641/F760 patch on TfR are H349 and
H350 (Figure 1C). These residues begin an a helix that
is identified from the EM structure and mutagenesis re-
sults to contribute significant contacts to the Tf/TfR in-
terface (Cheng et al., 2004) (Figure 1C). Histidine side
chains, with a typical pKa value of 6.5 (Fersht, 1985),
are likely to change protonation state over the pH range
to which the Tf/TfR complex is exposed during a round
of endo- and exocytosis (pH w5.6–7.4) (Dautry-Varsat
et al., 1983), suggesting that Tf residues H349 and
H350 could act as a pH sensor. To assess the role of
these Tf histidines in TfR binding and TfR-facilitated
iron release, we made site-directed mutants of FeC-Tf
(H349A-FeC-Tf and H350A-FeC-Tf) and evaluated them
in the binding and iron release assays described previ-
ously. All Tf mutants retain the iron binding properties
of FeC-Tf (Experimental Procedures).
We first used the SPR binding assay to determine the
affinities of FeC-Tf (iron-loaded) and apo-FeC-Tf (iron-
free) for wtTfR. The weaker affinity of FeC-Tf at pH 7.4
(KD = 58 nM) compared with the affinity of wild-type
Fe2-Tf (KD1 = 1.4 nM) results from the lack of iron in the
N-lobe. By contrast, as would be expected, apo-FeC-Tf
binds to TfR with approximately the same affinity as
apo-Tf (Table 1). The affinities of the iron-loaded forms
Structure
1618of H349A-FeC-Tf (KD = 58 nM) and H350A-FeC-Tf (KD = 71
nM) are not significantly different from the 58 nM KD of
FeC-Tf for TfR at pH 7.4, demonstrating that the substitu-
tions do not affect binding of the iron-loaded form of Tf
(Table 1). However, the iron-free forms of the mutants
(apo-H349A-FeC-Tf and apo-H350A-FeC-Tf) show some-
what reduced affinities for binding to TfR at pH 5.6 and
6.3 compared to wild-type FeC-Tf (Table 1). The pH 5.6
affinities, which are directly relevant to the iron release
assays, are 9.3 nM (apo-H349A-FeC-Tf) and 0.94 nM
(apo-H350A-FeC-Tf), representing 22-fold and 2.2-fold
reductions in binding affinity relative to wild-type apo-
FeC-Tf (KD = 0.42 nM) (Table 1), respectively.
We next measured the rates of iron release from the
FeC-Tf mutants in the presence and absence of TfR.
TfR binding increased the iron release rate from
H350A-FeC-Tf by 26-fold but did not significantly in-
crease the release rate from H349A-FeC-Tf. By compar-
ison, binding to TfR increases the rate of iron release
from wild-type FeC-Tf by 104-fold (Table 1). Thus, these
Tf substitutions partially (H350A) or completely (H349A)
abrogate the ability of TfR to facilitate iron release from
FeC-Tf at acidic pH.
We also substituted H349 and H350 in FeC-Tf with the
corresponding residues found in ovotransferrin, a trans-
ferrin family member that does not bind to human TfR
(Penhallow et al., 1986), to obtain H349K-FeC-Tf,
H350D-FeC-Tf, and the double mutant H349K/H350D-
FeC-Tf. Compared to the TfR binding affinity of wild-
type FeC-Tf at pH 7.4, the affinity of H349K-FeC-Tf is
unaltered, and the affinity of H349K/H350D-FeC-Tf is
reduced only 2-fold. Because the iron-loaded form of
H349K/H350D-FeC-Tf binds to TfR with nearly wild-
type affinity, the H350D substitution is unlikely to exert
Figure 4. Uptake of 125I-Fe2-Tf and
55Fe2-Tf by TRVb (TfR-Negative),
TRVb-wtTfR, and TRVb-W641A/F760A-TfR Cells
The values reported for the experiments conducted at 37ºC data
sets indicate the amount of internalized isotope after stripping the
material bound at the cell surface. Error bars represent the standard
deviation for three replicate measurements in one experiment.
Measurements of 125I-Fe2-Tf bound to cells at 4ºC and Western blots
(not shown) demonstrate that the TRVb-W641A/F760A-TfR cells ex-
press more TfR than the TRVb-wtTfR cells. In the experiment shown,
the amount of iron released from Fe2-Tf is reduced by 57%6 10% in
the TRVb-W641A/F760A-TfR cells as compared with the wtTfR-
expressing cells (calculated as described in Experimental Proce-
dures). In two other independent binding and uptake experiments
performed in triplicate, the reductions were 21%6 7% and 22%6 8%.much of an effect in isolation. We also measured the af-
finities of the apo forms of the mutant FeC-Tf proteins at
acidic pH. Despite the introduction of a longer side
chain, apo-H349K-FeC-Tf binds to TfR at pH 5.6 almost
as tightly as wild-type apo-FeC-Tf binds to TfR (KD =
2.6 nM versus 0.42 nM) and with a higher affinity than
apo-H349A-FeC-Tf (KD = 9.3 nM), suggesting that a pos-
itive charge at residue 349, as is the case for the histidine
at acidic pH in the wild-type protein, enhances binding
to TfR. Similar to the apo-H350A-FeC-Tf mutant, apo-
H350D-FeC-Tf has no significant effect on binding to TfR
at low pH. The double mutant, H349K/H350D-FeC-Tf,
exhibits similar binding properties as apo-H349K-FeC-Tf,
again suggesting that H350 plays no direct role in bind-
ing to TfR.
Iron release experiments conducted with these mu-
tants show that substitution of Tf residue H349 with
lysine, alone or in combination with the H350D substitu-
tion, eliminates TfR-stimulated iron release from Tf. The
H350D-FeC-Tf mutant, like H350A-FeC-Tf, shows some
TfR-facilitated enhancement of iron release (24-fold),
but not to the degree seen for wild-type FeC-Tf (104-
fold enhancement).
Discussion
An important aspect of iron homeostasis is the proper
transport, delivery, and uptake of iron into cells, as mis-
direction of toxic iron atoms can result in large-scale
oxidative damage (Halliwell and Gutteridge, 1990). In
vertebrates, this process is controlled, in part, by the in-
terplay of Tf with its cell surface receptor, TfR. Tf binds
ferric iron with high affinity (KD = 10
222 M) and exhibits
slow release kinetics at pH 7.4 (Aisen et al., 1978). How-
ever, when bound to TfR and exposed to acidic pH, iron
release from Tf is greatly accelerated (Bali et al., 1991;
Sipe and Murphy, 1991; Zak and Aisen, 2003). Within
the cell, Tf releases its bound iron within 2–3 min after
TfR-mediated endocytosis (Aisen and Leibman, 1973).
The requirements for TfR binding—a low pH environ-
ment, the correct anion concentration, and a biological
chelator for efficient iron release from Tf—ensure that
iron is released inside a cell, rather than from circulating
Tf in the bloodstream or from Tf bound to cell surface
TfR. Here, we use mutants of TfR and Tf to identify
some of the residues required for TfR-facilitated iron re-
lease from Tf at acidic pH.
In a previous site-directed mutagenesis study of TfR
(Giannetti et al., 2003), we noted differences in the bind-
ing footprints for Fe2-Tf and apo-Tf on the TfR surface.
Whereas apo-Tf and Fe2-Tf require the same binding de-
terminants in the central region of the TfR helical domain,
maximal apo-Tf binding requires two additional residues
in the TfR helical domain: W641 and F760. The side
chains of these residues are in van der Waals contact
with each other and form a hydrophobic patch on the
outside edge of the TfR helical domain (Figure 1A). We
hypothesized that these residues play a role in TfR-
stimulated iron release at low pH by binding and stabiliz-
ing the open form of Tf associated with apo-Tf at acidic
pH (Giannetti et al., 2003). We therefore combined
the two substitutions to make W641A/F760A-TfR and in-
vestigated its binding and iron release stimulating prop-
erties.
Mechanism of TfR-Stimulated Iron Release from Tf
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Bound to TfR
EPR spectra for FeC-Tf at pH 7.4 and 5.6 show
no detectable differences from each other
and are similar to spectra of the Tf C-lobe
alone and bound to TfR at pH 7.4 (Zak and
Aisen, 2003). The spectrum of FeC-Tf com-
plexed with wild-type TfR at pH 5.6 exhibits
a marked reduction of the high field peak,
which is not observed in the spectrum of
FeC-Tf bound to W641A/F760A-TfR at pH 5.6.Using an SPR-based binding assay, we demonstrated
that W641A/F760A-TfR binds Fe2-Tf at pH 7.4 with the
same affinity as wtTfR. However, its binding to apo-Tf
at acidic pH is reduced 400-fold relative to wtTfR
(Table 1). Using a fluorescence-based iron release as-
say, we showed that W641A/F760A-TfR does not stimu-
late iron release from Tf at low pH under conditions in
which wtTfR accelerates iron release from Tf by 100-
fold relative to unbound Tf (Figure 3). Instead, W641A/
F760A-TfR slows iron release 2-fold relative to free Tf,
suggesting that it actually stabilizes the iron-loaded
form, even at acidic pH in the presence of a chelator. Ad-
ditionally, cells expressing W641A/F760A-TfR acquire
iron from Tf less efficiently than cells expressing wtTfR,
most likely due to the slowed kinetics of iron release
from Tf bound to W641A/F760A-TfR. Although the bio-
chemical experiments show that W641A/F760A-TfR re-
duces iron release from Tf by 200-fold relative to wtTfR,
we see only a 20%–60% reduction of the efficiency of
iron acquisition from Tf inside the W641A/F760A-TfR-
expressing cells compared with cells expressing wtTfR
(Figure 4). That the reduction in cellular iron acquisition
is not as dramatic as the biochemical results suggests
that factors in endosomes contribute to the acceleration
of iron release from Tf inside cells. In addition, the cell-
based assay used here involved Fe2-Tf, which contains
two iron atoms per transferrin, whereas the biochemical
assay was done with FeC-Tf, which contains iron in the
C-lobe only. Thus, some of the acquired intracellular
iron could have been derived from the Tf N-lobe, which
is not predicted to be in the vicinity of TfR residues
W641 and F760 (Figure 1A).
Having identified TfR residues responsible for its activ-
ity in stimulating iron release from Tf, we sought to iden-
tify Tf residues involved in this process. Inspection of an
EM model of an Fe2-Tf/TfR complex (Cheng et al., 2004)
indicates that Tf residues H349 and H350 are near resi-
dues on TfR (W641 and F760) previously shown to be
functionally important in apo-Tf binding (Giannetti
et al., 2003) (Figure 6). Substitution of these histidines
does not reduce the TfR binding affinity of iron-loaded
FeC-Tf at pH 7.4, but substitution of H349 by alanine re-
duces the binding affinity of apo-FeC-Tf to TfR by 22-
fold at acidic pH. Interestingly, replacing H349 with the
larger residue lysine only reduces the binding affinity
by 6.2-fold at pH 5.6, suggesting that a positive charge
(on either the lysine or a protonated histidine at acidicpH) contributes to the binding energy at this position,
perhaps by forming cation-p interactions (Gallivan and
Dougherty, 1999) with the aromatic rings of the TfR
W641 and F760 side chains. Having ascertained that the
Tf substitutions affect binding of apo-Tf but not iron-
loaded Tf, we evaluated their effects on TfR-facilitated
iron release. We find that substitution of H349 abolishes,
and substitution of H350 somewhat reduces, TfR’s abil-
ity to enhance the iron release rate from Tf. Therefore, Tf
residue H349 is required for TfR facilitation of iron release
and H350 plays a lesser, but still significant, role.
Analyses of the effects of the Tf mutants on binding to
TfR and on TfR-facilitated iron release suggest that fac-
tors other than stabilizing the open (apo) form of Tf con-
tribute to TfR-mediated acceleration of iron release. For
example, the apo form of H350A-FeC-Tf shows no signif-
icant reduction in its affinity for TfR at acidic pH, but ac-
celeration of the iron release rate from H350A-FeC-Tf is
reduced 4-fold compared to FeC-Tf, suggesting a role
for H350 apart from affecting TfR binding. In addition,
the exact orientation of a positive charge at Tf position
349 must be important for TfR-facilitated iron release,
because we see complete loss of TfR-facilitated iron re-
lease when Tf H349 is substituted for lysine, a positively
charged residue with more conformational variability. It
seems unlikely that the abrogation of TfR-facilitated ac-
celeration of iron release from H349K-FeC-Tf results
from weaker TfR binding affinity of H349K-apo-FeC-Tf
compared to apo-FeC-Tf, because the free energy loss
for the mutant is only 1 kcal/mol at pH 5.6 (see Experi-
mental Procedures). This free energy difference is only
slightly greater than thermal background energy (RT)
at 25ºC (0.6 kcal/mol). If TfR’s effect on iron release is en-
tirely mediated through stabilizing the open form of Tf,
then destabilization of only 1 kcal/mol of free energy
should not be sufficient to completely abrogate the pro-
cess, as even thermal motion would then be expected to
act as a partial trigger of the process.
To explore the possibility that the Tf/TfR interface has
long-range effects on the iron binding site of the Tf
C-lobe, we monitored the iron ion in FeC-Tf as a function
of pH and wtTfR or W641A/F760A-TfR binding. The EPR
spectra of FeC-Tf alone at pH 5.6 and 7.4 show no detect-
able differences from spectra previously reported for Tf
alone at pH 7.4 (reviewed in Chasteen et al., 1994) or
for Tf bound to TfR (Zak and Aisen, 2003). However,
when mixed with wtTfR at pH 5.6, the high field peak
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Close-up of predicted interactions at the interface between TfR (brown and magenta) and the C-lobes of iron-loaded Tf (left) and a partially open
Tf (right) (salmon and blue) (based on the structure of an open form of iron-loaded camel lactoferrin) (Khan et al., 2001) to represent structural
changes that might occur during opening of the Tf C-lobe to release the bound iron ion.
TfR residues F760 and W641 are highlighted in green, Tf residues H349 and H350 are in cyan, and residues coordinating the bound iron in Tf are in
yellow. A dashed line drawn between TfR residue F760 (green) and the iron atom in Tf (red) (predicted distance ofw30 A˚) bisects the C-I/C-II
domain boundary in the Tf C-lobe. The left panel is drawn from PDB code 1SUV (Cheng et al., 2004) and the right panel was generated by super-
imposing the C-I domain of the open form of iron-bound camel lactoferrin (Khan et al., 2001) (right panel) upon the counterpart regions of the Fe2-
Tf molecule in the EM structure of the Fe2-Tf/TfR complex.near g0 = 4.3 is diminished. The effect on the spectrum re-
quires the presence of TfR residues W641 and F760 as it
is not observed in the spectrum of FeC-Tf bound to
W641A/F760A-TfR, which shows no detectable differen-
ces from the spectrum of FeC-Tf alone at pH 5.6. TfR res-
idues W641 and F760 are predicted to bew30 A˚ from the
Tf C-lobe iron ion (see Results) (Figure 6), implicating
long-range conformational changes in the TfR-facilitated
acceleration of iron release from Tf. The W641/F760
patch on TfR is likely to exert at least some of its effects
on Tf through Tf residue H349, which is predicted from
the EM model of the Fe2-Tf/TfR structure (Cheng et al.,
2004) to contact the W641A/F760 region of TfR. As de-
scribed above, when Tf H349 is substituted for lysine
(FeC-Tf-H349K), the resulting mutant maintains nearly
wild-type binding affinity for TfR at acidic pH, yet is not
stimulated by TfR binding to increase the iron release
rate. These results are consistent with a mechanism in
which Tf residue H349 is involved in receiving a signal
from the W641A/F760 patch on TfR, which triggers a con-
formational change cascade leading to changes in the vi-
cinity of the iron ion. This cascade likely involves partic-
ipation of Tf H350, mutation of which has no effect on TfR
binding but retards iron release.
These results, taken together with previous structural
and mutagenesis data regarding Tf binding to TfR
(Cheng et al., 2004; Giannetti et al., 2003; Liu et al.,
2003), allow speculation on the mechanism of TfR-
induced iron release from Tf at acidic pH. Structural and
mutagenesis data reveal that Fe2-Tf binds to TfR at ba-
sic pH with the C-lobe contacting a central region of the
TfR domain and the N-lobe contacting residues in the
TfR protease-like domain in the vicinity of Y123 (Figure
1A) (Cheng et al., 2004; Giannetti et al., 2003; Liu et al.,
2003). At basic pH, this binding interaction is likely to
stabilize Fe2-Tf in a closed conformation, as iron release
from TfR-bound Tf is slower than iron release from free
Tf (Bali et al., 1991; Zak and Aisen, 2003). Similarly, atacidic pH, binding to W641A/F760A-TfR slows the iron
release rate of FeC-Tf 2-fold relative to the release rate
from free FeC-Tf, suggesting that the mutant receptor fa-
vors binding the iron-loaded form of Tf, even at acidic
pH. At basic pH, Tf does not make energetically signifi-
cant contacts with the hydrophobic patch on TfR that in-
cludes W641 and F760 (Giannetti et al., 2003). Upon
acidification, the C-lobe of Tf makes new contacts to
TfR involving the hydrophobic patch defined by TfR
W641 and F760 (Giannetti et al., 2003). Our current re-
sults demonstrate that these contacts are critical for ac-
celerating iron release from the C-lobe of Tf at acidic pH.
Some of the new contacts are likely to directly involve Tf
residue H349 and direct or indirect interactions with
H350. A potential effect of acidic pH is that the positively
charged form of H349 present at low pH could make
a cation-p interaction with the aromatic side chain(s)
of TfR residues F760 and/or W641.
The observation that H349K-apo-FeC-Tf preserves
nearly wild-type binding affinity for TfR at acidic pH,
yet is not stimulated by TfR binding to increase the
rate of iron release, suggests that factors other than
TfR binding affinity are involved in the mechanism of
TfR-stimulated iron release. For example, conforma-
tional changes in Tf triggered by TfR binding and at least
in part transmitted by TfR residues W641/F760 and Tf
residues H349/H350 are likely to be important steps
toward iron release. Evidence for a conformational
change propagated over a large distance comes from
EPR results involving FeC-Tf bound to W641A/F760A-
TfR, which show that TfR residues W641 and F760 (pre-
dicted to interact with H349 on Tf) affect the environ-
ment of the iron ion located 30 A˚ away from the Tf/TfR
interface. Thus, we propose that TfR residues W641/
F760 and Tf residue H349 are involved in triggering
a conformational change cascade that leads to dissoci-
ation of iron-liganding residues in Tf and opening of the
Tf C-lobe. However, iron is not released efficiently until
Mechanism of TfR-Stimulated Iron Release from Tf
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concentration, bicarbonate protonation, and the pres-
ence of chelating agents (He and Mason, 2002). The re-
quirement for both chemical factors and TfR-induced
conformational changes prevents circulating Fe-Tf in
the blood from releasing potentially toxic iron atoms
anywhere except inside acidic recycling endosomes.
Experimental Procedures
Protein Expression and Purification
The W641A substitution was introduced into the pAcGP67A expres-
sion vector encoding F760A-TfR (Giannetti et al., 2003) using the
Quickchange protocol (Stratagene, La Jolla, CA) and the protein-
coding region was sequenced. His-tagged wtTfR and W641A/
F760A-TfR (N-terminal 63-His tag, factor Xa cleavage site, and resi-
dues 121–760 of human TfR) were expressed in baculovirus-infected
insect cells and purified from supernatants by a combination of Ni-
NTA and size exclusion chromatography as previously described
(Giannetti et al., 2003). Human Fe2-Tf was prepared from apo-Tf
(Sigma, St. Louis, MO) by incubation with bicarbonate and 3-fold ex-
cess of ferric ammonium sulfate. Production and Ni-NTA purification
of 63-His-tagged FeC-Tf (N-HisY95F/Y188F hTf-NG), a recombinant
Tf that binds iron only in the C-lobe, was accomplished as described
(Mason et al., 2004). Optical spectra and urea gel analysis confirmed
that FeC-Tf and FeC-Tf mutants are monoferric (data not shown) (Ma-
son et al., 2005) and experiments involving apo-Tfs were conducted
in the presence of 50 mM desferrioxamine, a potent iron chelator. His
tags on the FeC-Tf proteins, which complicate interpretation of TfR
binding data in the SPR assays (Mason et al., 2005), were removed
by factor Xa cleavage as described (Mason et al., 2005).
Biosensor Analyses
All biosensor experiments were carried out using a BIACORE 2000
instrument (BIACORE Life Sciences, Uppsala, Sweden). Interactions
between a protein immobilized on the sensor chip (the ‘‘ligand’’) and
a protein injected over the sensor surface (the ‘‘analyte’’) are moni-
tored in real time as a change in surface plasmon resonance as mea-
sured in resonance units (RU) (Malmqvist, 1993). Sensor chips were
prepared using standard primary amine coupling chemistry as de-
scribed in the BIACORE manual to attach 2000–4000 response units
(RU) of the anti-penta-His antibody (Qiagen, Valencia, CA), which
was used to capture TfR proteins from insect cell supernatants as
described (Giannetti et al., 2003). One of the four flow cells of
a CM5 sensor chip (BIACORE Life Sciences) was coupled with anti-
body but no TfR to act as a reference cell. Binding data were col-
lected, processed, and the kinetic curves were globally fit to a biva-
lent ligand model (diferric Tfs and apo-Tfs) in which KDs are derived
for two sequential binding events (A + B4AB, and AB + B4 BAB),
or to a 1:1 Langmuir binding model (monoferric Tfs) as described
(Giannetti and Bjorkman, 2004; Giannetti et al., 2003). Corrections
for statistical factors to KD1 and KD2 values derived from bivalent li-
gand models were not applied for ease of comparison with previous
mutagenesis studies (Giannetti et al., 2003). Free energy differences
were calculated as DDG = 2RTln[KD1(mutant)/KD1(wt)], where R is
the gas constant (1.99 3 1023 kcal mol21 K21) and T is the absolute
temperature (295 K).
Measurements of Iron Release Kinetics
The rates of iron release from the FeC-Tfs in this study, alone or in
complex with TfRs, were measured by an adaptation of the spectro-
fluorometric assay previously described (Zak and Aisen, 2003). A
QuantaMaster spectrofluorometer (Photon Technology Interna-
tional, South Brunswick, NJ) was used to measure steady-state fluo-
rescence. Fluorescence was measured by exciting the sample at
280 nm and collecting the emitted fluorescence at 330 nm. Experi-
ments were carried out at ambient temperature using 500 nM FeC-
Tf in 300 mM KCl, 4 mM EDTA. Data were recorded in 1 s intervals
immediately following the addition of FeC-Tf alone or FeC-Tf plus
a slight molar excess of TfR to a magnetically stirred cuvette con-
taining 1.8 ml of 0.1 M MES (pH 5.6), 300 mM KCl, 4 mM EDTA. These
conditions were chosen to compare rates with previous studies
(Halbrooks et al., 2003; Mason et al., 2002) and differ slightly fromthose described in another study (Zak and Aisen, 2003). Comparison
of iron release rates may only be made between experiments that
are performed under identical assay conditions.
Generation and Maintenance of Cell Lines
TRVb (a TfR-negative CHO cell derivative) and TRVb-1 (TRVb cells
expressing human TfR, here referred to as TRVb-wtTfR) were a gen-
erous gift from Dr. Tim McGraw (Cornell University) (McGraw et al.,
1987). The cell lines were maintained in Ham’s F12 media (Sigma)
supplemented with 10% fetal bovine serum, 2 mM glutamine, 12
mM glucose. Transfected cells were maintained in the same medium
supplemented with 400 mg/ml G418 (Calbiochem, San Diego, CA).
The pAcGP67A-W641A/F760A-TfR expression vector was di-
gested with Nde1 and Not1 to release a gene fragment containing
the W641A and F760 substitutions. The cDNA corresponding to the
remaining portions of TfR 50 to the Nde1 site (encoding the N-terminal
cytoplasmic domain, transmembrane, and stalk domains) was gen-
erated by digestion of a wtTfR gene with BamH1 and Nde1. The two
fragments were gel purified and ligated into the eukaryotic expres-
sion vector pcDNA 3.1 (Invitrogen, Carlsbad, CA), which had been
cut with BamH1 and Not1. The final construct (pcDNA 3.1 W641A/
F760A-TfR) was verified by DNA sequencing. The vector does not
contain an iron response element (Rouault and Klausner, 1997), and
thus the cells should express a constant level of TfR despite changes
in experimental conditions. The pcDNA 3.1 W641A/F760A-TfR
expression vector was transfected into TRVb cells (McGraw et al.,
1987) using Lipofectamine (GIBCO-BRL, Carlsbad, CA). Colonies
were selected in medium containing 800 mg/ml G418 and tested
for TfR expression by immunoblots (data not shown) using a mono-
clonal antibody to TfR (Vogt et al., 2003), and then cloned and
screened for TfR expression by immunoblots to ensure uniformity
and stability of expression.
Binding and Uptake of Radiolabeled Fe2-Tf by Transfected Cells
Human Fe2-Tf (Intergen, Purchase, NY) was labeled with Na [
125I]
(NEN Life Science Products, Boston, MA) using lactoperoxidase
and the specific activity determined as described previously (Warren
et al., 1997). The uptake of 50 nM 125I-Fe2-Tf for 30 min at 37ºC (5%
CO2) in TRVb, TRVb-wtTfR, and TRVb-W641A/F760A-TfR cells and
stripping of cell surface Tf with acid were done as previously de-
scribed (Davies et al., 2003). 55Fe (PerkinElmer Life Sciences, Nor-
ton, OH) loading of human apo-Tf and 55Fe2-Tf uptake was also per-
formed as previously described (Davies et al., 2003). 55Fe2-Tf was
89% saturated with iron as judged by the OD 465 nm/OD 280 nm ra-
tio (He and Mason, 2002) with a specific activity of 79,180 cpm/mg
protein. To account for nonspecific binding and internalization,
125I-Fe2-Tf and
55Fe2-Tf counts for the TRVb (TfR-negative) cells
were subtracted from counts measured for the TRVb-wtTfR and
the TRVb-W641A/F760-TfR cell lines. The ratio of specifically inter-
nalized 55Fe2-Tf to surface-bound
125I-Fe2-Tf was calculated to nor-
malize for differences in the expression levels of the two TfR-
expressing cell lines. The ratio for the TRVb-W641A/F760A-TfR cells
was divided by the ratio for the TRVb-wtTfR cells to derive the per-
cent iron taken up by the mutant relative to the wild-type cells. Sub-
tracting this percent from 1.0 yielded the percent reduction in iron
release for the TRVb-W641A/F760-TfR cells relative to the TRVb-
wtTfR cells. Because we are evaluating the efficiency of iron release
from TfR in endosomes, potential regulation of TfR expression by
iron levels (Rouault and Klausner, 1997) is not relevant.
EPR Spectroscopy
X-band EPR spectra of frozen solutions were collected using
a Bruker EMX spectrometer (Billerica, MA) equipped with an Oxford
helium cryostat (Devens, MA). One hundred microliters of a protein
solution (100 mM in FeC-Tf in all cases) was loaded into 4 mm outer
diameter quartz tubes (Wilmad, Buena, NJ) and frozen in a dry ice/
ethanol bath. Instrument settings were: microwave frequency,
9.378 GHz; microwave power, 0.08 mW; modulation amplitude, 4
G; temperature, 4 K; time constant, 41 ms; number of scans, three.
FeC-Tf/TfR complexes were prepared by mixing FeC-Tf in a 2/1 ratio
with wtTfR or with W641A/F760A-TfR. To circumvent the problem
that concentrated solutions of Tf or Tf/TfR complexes are prone to
aggregation and precipitation at low pH (Turkewitz et al., 1988), all
proteins were buffer exchanged by concentration and dilution into
Structure
1622a double buffer comprised of 20 mM PIPES, 100 mM MES, 150 mM
NaCl (pH 7.4). The protein solution was then rapidly mixed with an
experimentally determined volume of 5 M HCl to adjust the pH to
5.6 and frozen within 30 s. An iron release experiment conducted
in the absence of a chelator showed no iron loss over this time frame,
even in the presence of wtTfR (P.J.H., data not shown).
Supplemental Data
A supplemental figure can be found with this article online at http://
www.structure.org/cgi/content/full/13/11/1613/DC1/.
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